Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

02-07-2019 | Original Paper

The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder

Auteurs: Paul Herscu, Benjamin L. Handen, L. Eugene Arnold, Michael F. Snape, Joel D. Bregman, Lawrence Ginsberg, Robert Hendren, Alexander Kolevzon, Raun Melmed, Mark Mintz, Nancy Minshew, Linmarie Sikich, Ashraf Attalla, Brian King, Thomas Owley, Ann Childress, Harry Chugani, Jean Frazier, Charles Cartwright, Tanya Murphy, the Autism Speaks Autism Clinical Trials Network

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 9/2020

Abstract

Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that reduces obsessive–compulsive symptoms. There is limited evidence supporting its efficacy for repetitive behaviors (RRBs) in autistic spectrum disorder (ASD). We conducted a randomized controlled trial (RCT) of fluoxetine in 158 individuals with ASD (5–17 years). Following 14 treatment weeks (mean dose 11.8 mg/day), no significant differences were noted on the Children’s Yale-Brown Obsessive Compulsive Scale; the proportion of responders was similar (fluoxetine: 36%; placebo: 41%). There were similar rates of AEs (e.g., insomnia, diarrhea, vomiting); high rates of activation were reported in both groups (fluoxetine: 42%; placebo: 45%). Overly cautious dosing/duration may have prevented attainment of a therapeutic level. Results are consistent with other SSRI RCTs treating RRBs in ASD.

Trial Registration: clinicaltrials.gov Identifier: NCT00515320.

vorige artikel Age of First Walking and Associations with Symptom Severity in Children with Suspected or Diagnosed Autism Spectrum Disorder

volgende artikel Sex Differences in Externalizing and Internalizing Symptoms of Children with ASD

American Psychiatric Association (APA). (2000). Diagnostic and statistical manual of mental disorders TR (4th ed.). Arlington, VA: American Psychiatric Publishing.

American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders: DSM-5. Arlington, VA: American Psychiatric Publishing.

Asperger H. (1952/1991). Heilpa¨dagogik (U. Frith, Trans.). Vienna, Austria: Springer. In U. Frith, Autism and Asperger syndrome. Cambridge, England: Cambridge University Press. https://doi.org/10.1017/cbo9780511526770.

Bodfish, J. W., Symons, F. J., Parker, D. E., & Lewis, M. H. (2000). Varieties of repetitive behavior in autism: Comparisons to mental retardation. Journal of Autism and Developmental Disorders, 30, 237–243.PubMed

Brannan, A. M., Heflinger, C. A., & Bickman, L. (1997). The caregiver strain questionnaire: Measuring the impact on the family of living with a child with serious emotional disturbance. Journal of Emotional and Behavioral Disorders, 5(4), 212–222.

Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., et al. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45, 287–295.PubMed

Cook, E. H., Jr., Rowlett, R., Jaselskis, C., & Leventhal, B. L. (1992). Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 739–745.PubMed

Delong, G. R., Ritch, C. R., & Burch, S. (2002). Fluoxetine response in children with autistic spectrum disorders: Correlation with familial major affective disorder and intellectual achievement. Developmental Medicine and Child Neurology, 44(10), 652–659.PubMed

Dominick, K. C., Davis, N. O., Lainhart, J., Tager-Flusberg, H., & Folstein, S. (2007). Atypical behaviors in children with autism and children with a history of language impairment. Research in Developmental Disabilities, 28, 145–162.PubMed

Dunlap, G., Dyer, K., & Koegel, R. L. (1983). Autistic self-stimulation and intertrial interval duration. American Journal of Mental Deficiency, 88, 194–202.PubMed

Emslie, G. J., Kennard, B. D., Mayes, T. L., Nightingale-Teresi, J., Carmody, T., Hughes, C. W., et al. (2008). Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. The American Journal of Psychiatry, 165(4), 459–467.PubMedPubMedCentral

Emslie, G. J., Rush, A. J., & Weinberg, W. A. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54(11), 1031–1037. https://doi.org/10.1001/archpsyc.1997.01830230069010.CrossRefPubMed

Fatemi, S. H., Realmuto, G. M., Khan, L., & Thuras, P. (1998). Fluoxetine in treatment of adolescent patients with autism: A longitudinal open trial. Journal of Autism and Developmental Disorders, 28, 303–307.PubMed

Findling, R. L., Pagano, M. E., McNamara, N. K., Stansbrey, R. J., Faber, J. E., Lingler, J., et al. (2009). The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: A pilot randomized placebo-controlled trial. Child and Adolescent Psychiatry and Mental Health, 3(1), 11. https://doi.org/10.1186/1753-2000-3-11.CrossRefPubMedPubMedCentral

Gabriels, R. L., Cuccaro, M. L., Hill, D. E., Ivers, B. J., & Goldson, E. (2005). Repetitive behaviors in autism: Relationships with associated clinical features. Research in Developmental Disabilities, 26, 169–181.PubMed

Guy, W. (1976). ECDEU assessment manual for psychopharmacology, Publication No. 76-338. Washington, DC: U.S. DHEW, NIMH.

Heiligenstein, J. H., Hoog, S. L., Wagner, K. D., Findling, R. L., Galil, N., Kaplan, S., et al. (2006). Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: A pilot study. Journal of Child and Adolescent Psychopharmacology, 16(1–2), 207–217. https://doi.org/10.1089/cap.2006.16.207.CrossRefPubMed

Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S., et al. (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30(3), 582–589.PubMed

Hollander, E., Phillips, A., King, B. H., Guthrie, D., Aman, M. G., Law, P., et al. (2004). Impact of recent findings on study design of future autism clinical trials. CNS Spectrum, 9, 49–56.

Hollander, E., Soorya, L., Chaplin, W., Swanson, E., Anagnostou, E., Wasserman, S., et al. (2012). A double-blind, placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autistic disorder. American Journal of Psychiatry, 169(3), 292–299.PubMed

Honey, E., Leekam, S., Turner, M., & McConachie, H. (2007). Repetitive behaviour and play in typically developing children and children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 37, 1107–1115.PubMed

Jiujias, M., Kelley, E., & Hall, L. (2017). Restricted, repetitive behaviors in autism spectrum disorder and obsessive-compulsive disorder: A comparative review. Child Psychiatry and Human Development, 48, 944–959.PubMed

Joyce, C., Honey, E., Leekam, S. R., Barrett, S. L., & Rodgers, J. (2017). Anxiety, intolerance of uncertainty and restricted and repetitive behaviour: Insights directly from young people with ASD. Journal of Autism and Developmental Disorders, 47, 3789–3802.PubMed

Kanner, L. (1973). Childhood psychosis: Initial studies and new insights. Washington, DC: Winston.

King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., et al. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives of General Psychiatry, 66(6), 583–590.PubMedPubMedCentral

Koegel, R. L., & Covert, A. (1972). The relationship of self-stimulation to learning in autistic children. Journal of Applied Behavior Analysis, 5, 381–387.PubMedPubMedCentral

Kogan, M. D., Vladutiu, C. J., Schieve, L. A., Ghandour, R. M., Blumberg, S. J., Zablotsky, B., et al. (2018). The prevalence of parent-reported autism spectrum disorder among US children. Pediatrics, 142(6), 2017–4161. https://doi.org/10.1542/peds.CrossRef

Kolevzon, A., Mathewson, K. A., & Hollander, E. (2006). Selective serotonin reuptake inhibitors in autism: A review of efficacy and tolerability. Journal of Clinical Psychiatry, 67, 407–414.PubMed

Lam, K. S. L., & Aman, M. G. (2007). The repetitive behavior scale-revised: Independent validation in individuals with autism spectrum disorders. Journal of Autism and Developmental Disorders, 37, 855–866.PubMed

Lam, K. S. L., Bodfish, J. W., & Piven, J. (2008). Evidence for three subtypes of repetitive behavior in autism that differ in familiarity and association with other symptoms. Journal of Child Psychology and Psychiatry, 49, 1193–1200.PubMed

Langen, M., Schnack, H. G., Nederveen, H., Bos, D., Lahuis, B. E., de Jonge, M. V., et al. (2009). Chnages in the developmental trajectories of striatum in autism. Biological Psychiatry, 66(4), 327–333.PubMed

Lecavalier, L. (2006). Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification. Journal of Autism and Developmental Disorders, 36, 1101–1114.PubMed

Lewin, A. B., Wood, J. J., Gunderson, S., Murphy, T. K., & Storch, E. A. (2011). Phenomenology of comorbid autism spectrum and obsessive-compulsive disorders among children. Journal of Developmental and Physical Disabilities, 23(6), 543–553.

Liebowitz, M. R., Turner, S. M., Piacentini, J., Beidel, D. C., Clarvit, S. R., Davies, S. O., et al. (2002). Fluoxetine in children and adolescents with OCD: A placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41(12), 1431–1438.PubMed

Lord, C., DiLavorne, P. C., & Risi, S. (2002). Autism diagnostic observation schedule. Torrance, CA: Western Psychological Services.

Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K., & Bishop, S. L. (2012). Autism diagnostic observation schedule (ADOS-2) (2nd ed.). Torrance, CA: Western Psychological Services.

Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659–685.PubMed

Madden, J. M., Lakoma, M. D., Lynch, F. L., Rusinak, D., Owen-Smith, A. A., Coleman, K. J., et al. (2017). Psychotropic medication use among insured children with autism spectrum disorder. Journal of Autism and Developmental Disorders, 47, 144–154.PubMedPubMedCentral

Markarian, Y., Larson, M. J., Aldea, M. A., Baldwin, S. A., Good, D., Berkeljon, A., et al. (2010). Multiple pathways to functional impairment in obsessive-compulsive disorder. Clinical Psychology Review, 30(1), 78–88.PubMed

McDougle, C., Kresch, L. E., Goodman, W. K., Naylor, S. T., & Volkmar, F. R. (1995). A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. American Journal of Psychiatry, 152, 773.

Meyer, J. H. (2004). Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: An [11C]DASB positron emission tomography study. American Journal of Psychiatry, 161, 826–835.PubMed

Morrison, K., & Rosales-Ruiz, J. (1997). The effect of object preferences on task performance and stereotypy in a child with autism. Research in Developmental Disabilities, 18, 127–137.PubMed

Novotny, S., Hollander, E., Phillips, A., Allen, A., Wasserman, S., & Iyengar, R. (2004). Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders. International Journal of Neuropsychopharmacology, 7(3), 249–254.PubMed

Preskorn, S. (2011). What do the terms “Drug-specific response/remission rate” and “Placebo” really mean? Journal of Psychiatric Practice, 17(6), 420–424.PubMed

Preskorn, S. (2012). The use of biomarkers in psychiatric research: How serotonin transporter occupancy explains the dose-response curves of SSRIs. Journal of Psychiatric Practice, 18(1), 38–45.PubMed

Riddle, M. A., Scahill, L., King, R. A., Hardin, M. T., Anderson, G. M., Ort, S. I., et al. (1992). Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31(6), 1062–1069.PubMed

Rodgers, J., Glod, M., Connolly, B., & McConachie, H. (2012). The relationship between anxiety and repetitive behaviors in autism spectrum disorder. Journal of Autism and Developmental Disorders, 42, 2404–2409.PubMed

Runco, M. A., Charlop, M. H., & Schreibman, L. (1986). The occurrence of autistic children’s self-stimulation as a function of familiar versus unfamiliar stimulus conditions. Journal of Autism and Developmental Disorders, 16, 31–44.PubMed

Rutter, M., Le Couteur, A., & Lord, C. (2003). ADI-R: Autism diagnostic interview-revised (ADI-R). Los Angeles, CA: Western Psychological Services.

Ruzzano, L., Borsboom, D., & Geurts, H. M. (2015). Repetitive behaviors in autism and obsessive-compulsive disorder: New perspectives from a network analysis. Journal of Autism and Developmental Disorders, 45, 192–202.PubMed

Scahill, L., McDougle, C. J., Williams, S. K., Dimitropoulos, A., Aman, M. G., McCracken, J. T., et al. (2006). Children’s Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 45(9), 1114–1123.PubMed

Sonawalla, S. B., & Rosenbaum, J. F. (2002). Placebo response in depression. Dialogues in Clinical Neuroscience, 4(1), 105–113.PubMedPubMedCentral

Titel: The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder
Auteurs: Paul Herscu
Benjamin L. Handen
L. Eugene Arnold
Michael F. Snape
Joel D. Bregman
Lawrence Ginsberg
Robert Hendren
Alexander Kolevzon
Raun Melmed
Mark Mintz
Nancy Minshew
Linmarie Sikich
Ashraf Attalla
Brian King
Thomas Owley
Ann Childress
Harry Chugani
Jean Frazier
Charles Cartwright
Tanya Murphy
the Autism Speaks Autism Clinical Trials Network
Publicatiedatum: 02-07-2019
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 9/2020
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-019-04120-y

Andere artikelen Uitgave 9/2020

Anxiety and Depression from Adolescence to Old Age in Autism Spectrum Disorder

Original Paper

Modified Checklist for Autism in Toddlers Revised (MCHAT-R/F) in an Urban Metropolitan Sample of Young Children in Turkey

Original Paper

Self-categorization and Autism: Exploring the Relationship Between Autistic Traits and Ingroup Favouritism in the Minimal Group Paradigm

Original Paper

Improving the Diagnosis of Autism Spectrum Disorder in Fragile X Syndrome by Adapting the Social Communication Questionnaire and the Social Responsiveness Scale-2

Original Paper

High School Experiences and Support Recommendations of Autistic Youth

Original Paper

Parent Perspectives Towards Genetic and Epigenetic Testing for Autism Spectrum Disorder

Open Access
Original Paper